THE USE OF INTRAAORTIC BALLOON COUNTERPULSATION IN ACUTE MYOCARDIAL-INFARCTION AND HIGH-RISK CORONARY ANGIOPLASTY

被引：4

作者：

ARMSTRONG, B ^{[1
]}

ZIDAR, JP ^{[1
]}

OHMAN, EM ^{[1
]}

机构：

[1] DUKE UNIV,MED CTR,DURHAM,NC 27710

来源：

JOURNAL OF INTERVENTIONAL CARDIOLOGY | 1995年 / 8卷 / 02期

关键词：

D O I：

10.1111/j.1540-8183.1995.tb00530.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with complex coronary arterial stenoses, decreased ejection fraction, or acute myocardial infarction are at increased risk during percutaneous coronary interventions. Intraaortic balloon counterpulsation (IABP) can provide benefit in such cases by several mechanisms. Myocardial perfusion is improved and left ventricular afterload is reduced by balloon counterpulsation. Patients with cardiogenic shock clearly benefit from balloon counterpulsation until revascularization can be performed. Recent studies have documented the utility of balloon counterpulsation in patients undergoing angioplasty as treatment for an acute myocardial infarction. Balloon counterpulsation is also an effective means to reduce ischemia and provide hemodynamic support during complex percutaneous coronary interventions. This review will summarize the benefits, indications, and complications of balloon counterpulsation during acute myocardial infarction and high-risk coronary angioplasty.

引用

页码：185 / 191

页数：7

共 63 条

[1]

Moulopoulos SD, Topaz S, Kolff WL, Diastolic balloon pumping with carbon dioxide) in the aorta—a mechanical assistance to the failing circulation, Am Heart J, 63, pp. 669-675, (1962)

[2]

Kantrowitz A, Tjonneland S, Freed PS, Et al., Initial clinical experience with intraaortic balloon pumping in cardiogenic shock, JAMA, 203, pp. 135-140, (1968)

[3]

Goldenberg IF, Nonpharmacologic management of cardiac arrest and cardiogenic shock, Chest, 102, pp. 596S-616S, (1992)

[4]

Logue B, Bone D, Kaplan J, The diagnosis and management of mechanical defects due to myocardial infarction, Cardiovasc Rev Rep, 1, pp. 446-459, (1980)

[5]

Wall TC, Califf RM, George BS, Et al., Accelerated plasminogen activator dose regimens for coronary thrombolysis, JACC, 19, pp. 482-489, (1992)

[6]

Katz ES, Tunick PA, Kronzon I, Observations of coronary Clow augmentation and balloon function during intraaortic balloon counterpulsation using transesophageal echocardiography, Am J Cardiol, 69, pp. 1635-1639, (1992)

[7]

Mueller H, Ayres SM, Conklin EF, Et al., The effects of intraaortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction, J Clin Invest, 50, pp. 1885-1900, (1971)

[8]

Gurbel PA, Anderson RD, MacCord CS, Et al., Arterial diastolic pressure augmentation by intra‐aortic balloon counter‐pulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy, Circulation, 89, pp. 361-365, (1994)

[9]

Williams DL, Korr KS, Gerwirtz H, Et al., The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina, Circulation, 66, pp. 593-597, (1982)

[10]

Weber KT, Janicki JS, Intraaortic balloon counterpulsation: A review of physiological principles, clinical results, and device safety, Annals of Thoracic Surgery, 17, pp. 602-636, (1974)

← 1 2 3 4 5 6 7 →